AzTrials
AzTrials

Situational AnxietyNCT03169374

Virtual Reality for Anxiety Management in Mechanically Vented Patients

A study testing Virtual Reality Technology in people with Situational Anxiety, run by University of Minnesota at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The purpose of this study is to investigate the safety and feasibility of virtual reality for anxiety treatment in mechanically ventilated patients. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Situational Anxiety
What is being tested?
Virtual Reality Technology
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
10 participants
Where
1 siteUnited States
Study dates
9 Nov 2017to 31 Aug 2019
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Age: 18 years or older
  • Mechanically ventilated; defined as having an endotracheal tube or tracheostomy and requiring continuous support from a mechanical ventilator.
  • Able to spontaneously maintain a state of wakefulness and alertness and able to follow commands
  • Able to communicate with research staff; defined as writing or head nods/shakes

Who cannot join

  • Delirious; defined as positive on the Confusion Assessment Method for the ICU (CAM-ICU +)
  • Expected to be liberated from ventilator within 12 hours of potential enrollment
  • Existence of skull injury or recent surgery (craniectomy) which precludes safely wearing VR visor
  • Impaired ability to see or hear, as determined by study investigator
  • Ventilator settings with positive end expiratory pressure (PEEP) greater than 10
  • Inability to be safely removed from physical restraints for VR (virtual reality) sessions
Show all 11Show fewer
  • Chronic ventilator dependence prior to the present hospitalization
  • Lacking capacity to consent for one's self
  • Known difficult airway; based on review of intubation note
  • Tracheostomy performed within last seven days
  • Pre-existing symptoms overlapping with major symptoms of cyber-sickness: Headache, Vertigo (dizziness), Ataxia (tremor with movement), Nausea, Vomiting.

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Fairview Southdale Hospital

    Edina, Minnesota, 55435

Other trials in United States

About this study

The purpose of this study is to investigate the safety and feasibility of virtual reality for anxiety treatment in mechanically ventilated patients.

Read the detailed description

Mechanically ventilated patients (those on a breathing machine) often experience heightened levels of anxiety and discomfort. This is usually treated by using sedative medications, however these drugs often have unintended side effects. This study will investigate the safety and feasibility of using relaxing virtual reality environments for reduction of anxiety in mechanically ventilated patients.

Being tested
Virtual Reality Technology
Keywords
Virtual Reality, Mechanical Ventilation, Anxiety
Medical subject headings
Anxiety Disorders

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Virtual Reality TechnologyDevice

    Patients in this arm will participate in virtual reality sessions planned for 5 minutes at a time, during which they are shown relaxing virtual environments.

Study groups in NCT03169374
Study groupRoleWhat they receive
Virtual Reality TechnologyExperimentalVirtual Reality Therapy
Receives: Device: Virtual Reality Technology

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Incidence of safety events

    Occurrence rate of safety events, defined as cardiac arrhythmias, hypotension, hypertension, oxygen desaturation, falls to the floor, or unintentional removal of a medical tube or device.

    Measured: Immediately following treatment session

Secondary outcomes (1)
  1. Change in anxiety level during virtual reality treatment

    Change in anxiety score from pre- to post-virtual reality treatment using a visual analog scale.

    Measured: Immediately following treatment session

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted30 May 2017
  2. Study start9 Nov 2017
  3. Primary completion31 Aug 2019
  4. Study completion31 Aug 2019

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Device feasibility
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
10 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03169374
Sponsor's protocol ID
STUDY00000220
Status last verified
Sep 2021
First submitted
17 May 2017
Last updated
1 Oct 2021
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Virtual Reality Technology in people with Situational Anxiety, run by University of Minnesota at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 11 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 1 Oct 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Incidence of safety events (time frame: Immediately following treatment session). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 1 Oct 2021.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in